Open an account

Quanterix

QTRX · NASDAQ

$2.72−$0.05 (−1.81%)TodayMarket closed ·
Prev close $2.77

About QTRX

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2017-12-07. The firm is focused on ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development proprietary digital Simoa detection technology enables customers to reliably detect protein biomarkers at ultra-low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. Its Simoa bead-based digital immunoassays utilize the basic principles of conventional bead-based sandwich ELISA. The HD-X is the Company's flagship instrument that empowers biomarker research and accelerates drug development. Its SR-X instrument is a compact benchtop instrument with a lower price point, more flexible assay preparation, and a wider range of applications. The firm's Spatial Biology solutions measure protein expression and cellular phenotypes within intact tissue while preserving spatial context and tissue architecture.

Employees
450
Headquarters
Billerica, Massachusetts
Listed
Dec 7, 2017
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
quanterix.com

QTRX key statistics

Market cap
128.64M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
526.15K
Volume
536.50K
Open price
$2.77
High today
$2.85
Low today
$2.71
52 Week high
$8.77
52 Week low
$2.15

Quanterix (QTRX) at a glance

Quanterix (QTRX) last traded at $2.72, with a market cap of 128.64M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.71 and $2.85. The current price is 0.4% above the day's low and 4.4% below its high.

Volume so far is 536.50K shares, in line with the average of 526.15K shares a day.

Over the past year Quanterix has ranged from $2.15 to $8.77, and now sits 9% of the way up that range.

Quanterix met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$1.04 per share against an estimate of -$0.4692.

The average analyst price target is $3.06, 12.5% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 2 analyst ratings say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 5 analystsAvg $3.06
Low
$3.03
Now
$2.72
High
$3.15

QTRX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 17.0% on average.

  1. Q3 FY24: reported -$0.22 per share against an estimate of -$0.2499
  2. Q4 FY24: reported -$0.30 per share against an estimate of -$0.2601
  3. Q1 FY25: reported -$0.42 per share against an estimate of -$0.4454
  4. Q2 FY25: reported -$0.57 per share against an estimate of -$0.3672
  5. Q3 FY25: reported -$0.73 per share against an estimate of -$0.5406
  6. Q4 FY25: reported -$0.49 per share against an estimate of -$0.459
  7. Q1 FY26: reported -$0.37 per share against an estimate of -$0.5542
  8. Q2 FY26: reported -$1.04 per share against an estimate of -$0.4692

QTRX news

  • Press releaseBusiness Wire

    Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals

  • Press releaseBusiness Wire

    Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026

  • Press releaseBusiness Wire

    Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Press releaseBusiness Wire

    Quanterix Names Dr. Yuri Fesko Chief Medical Officer

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • 12 Health Care Stocks Moving In Monday's Intraday Session

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releaseBusiness Wire

    Quanterix Names Jim Gute Chief Commercial Officer

Similar companies

Companies in the same industry as Quanterix

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.